How Fifehan Osinkalu is building a safe community for women and creatives
Fifehan Osinkalu describes herself as a very spirited person, who is also committed and loyal to the things that she ...
Read moreDetails
Day: July 14, 2023
Access Bank to acquire Standard Chartered’s subsidiaries in sub-Saharan Africa
Access Bank’s pan-African drive sees another boon: an acquisition that could make it one of the continent’s topmost banks. Access ...
Read moreDetails
Safaricom to strengthen spark venture with new venture capital arms
Safaricom already has an investment arm, Spark Venture Fund, which has invested in several local startups. However, there are plans ...
Read moreDetails
Bayer to present new Kerendia™ (finerenone) data from comprehensive clinical trial program across a broad range of patients with chronic kidney disease and type 2 diabetes
Berlin, June 3, 2022, - Bayer will present new renal and cardiovascular data from the comprehensive Kerendia™ (finerenone) clinical trial ...
Read moreDetails
BlueRock Therapeutics Announces Completion of Enrollment of Phase 1 Trial in Patients with Parkinson’s Disease
CAMBRIDGE, Mass., May 31, 2022 - BlueRock Therapeutics LP, a clinical stage biopharmaceutical company and wholly-owned subsidiary of Bayer AG, ...
Read moreDetails
Bayer makes 160 million U.S. dollar commitment to Zero Hunger Pledge
Monheim, Germany, May 24, 2022 - Joining like-minded companies in the private sector, Bayer has signed the Zero Hunger Private ...
Read moreDetails
Two large Xarelto™ studies support effectiveness of dual pathway inhibition in patients with coronary artery disease and/or peripheral artery disease
Berlin, May 23, 2022 - Two studies with Bayer´s Factor Xa inhibitor rivaroxaban (Xarelto), the Long-Term Open Label Extension (LTOLE) ...
Read moreDetails
New data support renal and cardiovascular benefits of Kerendia™ (finerenone) in patients with and without history of left ventricular hypertrophy and chronic kidney disease and type 2 diabetes
Berlin, May 23, 2022 - Late-breaking data from an exploratory post hoc analysis from FIDELITY, a prespecified pooled analysis of ...
Read moreDetails
JOE BONAMASSA estrena la revisión del clásico de GUITAR SLIM “WELL, I DONE GOT OVER IT”, extraido de su próximo álbum “BLUES DELUXE VOL.2”
En su próximo álbum 'Blues Deluxe Vol. 2', la superestrella Joe Bonamassa está volviendo a sus raíces y haciendo un ...
Read moreDetails
EXTREME invita a las nuevas generaciones a grabar su propia versión del exitoso tema de su último disco “RISE”
Ayer jueves a las 18:00 CEST el sello earMUSIC lanzó no solo una versión alternativa del video de “RISE” (que ...
Read moreDetails
The Earth News is an independent English-language daily published Website from all around the World News